(Q40283373)

19 September 2017

title

Successful treatment of ebola virus-infected cynomolgus macaques with monoclonal antibodies (English)

1 reference

19 September 2017

main subject

Orthoebolavirus zairense

0 references

1 reference

1 reference

Jonathan Audet

2

0 references

Gary Wong

3

object named as

Gary Wong

1 reference

19 September 2017

11

Gary P Kobinger

1 reference

19 September 2017

1

Xiangguo Qiu

1 reference

19 September 2017

8

Frank Plummer

1 reference

19 September 2017

Stephane Pillet

4

1 reference

19 September 2017

Alexander Bello

5

1 reference

19 September 2017

Teresa Cabral

6

1 reference

19 September 2017

Jim E Strong

7

1 reference

19 September 2017

Cindy R Corbett

9

1 reference

19 September 2017

Judie B Alimonti

10

1 reference

19 September 2017

language of work or name

English

0 references

publication date

1 June 2012

1 reference

Science Translational Medicine

19 September 2017

published in

1 reference

19 September 2017

volume

4

1 reference

19 September 2017

issue

138

1 reference

19 September 2017

page(s)

138ra81

1 reference

Ebola haemorrhagic fever: experimental infection of monkeys

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003876

Disease modeling for Ebola and Marburg viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003876

Replication, pathogenicity, shedding, and transmission of Zaire ebolavirus in pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003876

Recent advances in Ebolavirus vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003876

Effective post-exposure treatment of Ebola infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003876

Severe protein C deficiency predicts early death in severe sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003876

Safety and dose relationship of recombinant human activated protein C for coagulopathy in severe sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003876

Mechanisms underlying coagulation abnormalities in ebola hemorrhagic fever: overexpression of tissue factor in primate monocytes/macrophages is a key event

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003876

Recombinant human activated protein C for the postexposure treatment of Ebola hemorrhagic fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003876

Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: a study in rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003876

Advanced antisense therapies for postexposure protection against lethal filovirus infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003876

Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003876

Mucosal immunization of cynomolgus macaques with the VSVDeltaG/ZEBOVGP vaccine stimulates strong ebola GP-specific immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003876

Ebola hemorrhagic fever: evaluation of passive immunotherapy in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003876

Evaluation of immune globulin and recombinant interferon-alpha2b for treatment of experimental Ebola virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003876

Pre- and postexposure prophylaxis of Ebola virus infection in an animal model by passive transfer of a neutralizing human antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003876

Neutralizing antibody fails to impact the course of Ebola virus infection in monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003876

Lymphocyte death in a mouse model of Ebola virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003876

Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003876

Clinical virology of Ebola hemorrhagic fever (EHF): virus, virus antigen, and IgG and IgM antibody findings among EHF patients in Kikwit, Democratic Republic of the Congo, 1995.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003876

Characterization of Zaire ebolavirus glycoprotein-specific monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003876

Ebola GP-specific monoclonal antibodies protect mice and guinea pigs from lethal Ebola virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003876

An analysis of features of pathogenesis in two animal models of Ebola virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003876

Preparation and use of hyperimmune serum for prophylaxis and therapy of Ebola virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003876

Postexposure antibody prophylaxis protects nonhuman primates from filovirus disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003876

CD8+ cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003876

Vaccines: correlates of vaccine-induced immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003876

Assessment of a vesicular stomatitis virus-based vaccine by use of the mouse model of Ebola virus hemorrhagic fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003876

A neutralizing human monoclonal antibody protects african green monkeys from hendra virus challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003876

Immunotherapy: past, present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003876

In vitro and in vivo characterization of recombinant Ebola viruses expressing enhanced green fluorescent protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003876

10.1126/SCITRANSLMED.3003876

21 January 2018

Identifiers

DOI

1 reference

19 September 2017

1 reference